We have helped to secure more than $80 billion in jury verdicts and settlements since 1955.
Were you diagnosed with Cutaneous T-Cell Lymphoma (CTCL) after using Dupixent (dupilumab)? You may be entitled to compensation.
Dupixient lawsuits are now being investigated on behalf of patients who developed serious side effects, including Cutaneous T-Cell Lymphoma, after taking this popular eczema and asthma medication. If you or a loved one used Dupixent and later developed CTCL or another form of T-Cell Lymphoma, our legal team at Levin Papantonio is ready to help you seek justice.
👉 Call us now or fill out the form on this page for a free, no-obligation case review. There are no fees unless we win your case.
Dupixent, also known by its generic name dupilumab, is a prescription drug approved by the FDA to treat conditions like:
It works by blocking certain proteins involved in inflammation. While many patients have found relief with Dupixent, some have reported devastating side effects — including the development or worsening of Cutaneous T-Cell Lymphoma, a rare but aggressive form of cancer.
Patients and doctors have raised alarms about Dupixent possibly triggering or worsening T-cell lymphomas, especially CTCL. These are cancers that affect the immune system and often appear on the skin as rashes, lesions, or tumors.
Some of the warning signs of CTCL include:
Some patients using Dupixent were misdiagnosed with eczema or dermatitis when they were actually developing lymphoma. In certain cases, continued use of the drug made the cancer worse.
Lawsuits are being filed by individuals who used Dupixent and were later diagnosed with T-cell lymphoma. These lawsuits claim that:
As of now, these lawsuits are in the early stages, but the number of claims is expected to grow as more patients become aware of the link between Dupixent and T-Cell Lymphoma.
Several medical reports and studies have suggested that Dupixent may be tied to a worsening of existing but undiagnosed CTCL. These include:
These findings have pushed doctors to re-evaluate how and when to prescribe Dupixent — especially when patients show unusual skin reactions that don’t improve.
Every case is different, and settlements depend on the severity of harm, medical expenses, and long-term impact. That said, if successful, a Dupixient lawsuit could recover damages for:
There is no class action at this time. These are expected to be individual lawsuits or consolidated multidistrict litigation (MDL) cases.
👉 Time limits apply, and your right to compensation may expire.
Hiring an experienced pharmaceutical injury lawyer can help you:
At Levin Papantonio, we’ve handled some of the most high-profile drug injury cases in the country. Our attorneys know how to stand up to big pharmaceutical companies — and win.
Levin Papantonio is one of the most respected law firms in the U.S. for mass tort and pharmaceutical litigation. Here’s what sets us apart:
We treat every client with compassion and fight every case with power.
You may be eligible if you:
Even if you’re unsure, it’s worth reaching out. We’ll review your case for free and let you know your legal options.
👉 Call us now or fill out the form to get started. There’s no cost and no pressure.
If you or someone you love has suffered serious side effects after using Dupixent, you don’t have to face it alone. Let our team at Levin Papantonio fight for the justice and compensation you deserve.
📞 Call (888) 381-4847.🖋️ Fill out the secure form on this page💼 100% Free Consultation | No Fees Unless We Win
By selecting "I Agree" below and clicking the "Submit for Free Evaluation” button, I agree to the POLICIES AND DISCLAIMERS, including arbitration provision therein, and consent to receive marketing emails, calls and/or texts, including those made using an automated system and/or artificial/prerecorded voice message, from or on behalf of Levin Papantonio Law Firm (“LP”) / Pensacola, FL / 850-435-7000 / levinlaw.com, regarding their services in response to my inquiry at the telephone number(s) provided above, even if that number is currently listed on any state, federal or corporate Do Not Call registry. I understand my consent to receive automated marketing calls/texts is not required as a condition of purchasing any services. I can revoke my consent at any time. Review LP's Terms and Conditions and Privacy Policy here.
Opt in to Receive Calls, Text Messages, and Emails
By checking the below box and clicking “SUBMIT”, I agree to the Terms of the Policies and Procedures of the referenced entity, including individual arbitration provisions therein. I also consent to receive marketing emails, calls, and/or text messages, including those made using an automated system and/or artificial/prerecorded voice message (including artificial intelligence (AI)-generated voices), from or on behalf of the referenced entity regarding its services and/or my inquiry at the telephone number provided above, even if currently listed on any state or federal Do Not Call registry. I understand that my consent to receive automated marketing calls/texts is not required as a condition of purchasing any services, and that I may opt out of such calls/texts at any time.